ALUR Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 3.14%, SMA50 -11.29%, SMA200 -39.14%). The stock’s 14-day RSI is 48.43 (neutral), while the ATR of 0.23 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -70.1% below its high and over 31.58% above its low. Average 10-day trading volume of 1.96 thousand shares is below the 3-month average of 2.51 thousand, indicating normal recent market interest.

Allurion Technologies Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.25. This means the shares are trading below this model’s fair value.

Allurion Technologies Inc. generated EPS of -$7.33 over the past year. Five-year average earnings growth is -618.79%. Wall Street analysts project EPS growth of 52.56% annually over the next five years. Analyst sentiment is neutral. Analyst rating data shows there are 0 Strong Buy ratings, 1 Buy ratings, 1 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $3.00 to $2.50. The high target offers 177.78% upside. The low target suggests 131.48% downside. The mean target is $2.75. This offers 154.63% upside. Allurion Technologies Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended May 27, 2026, missed forecasts by 35.29%. The prior quarter beat by 35.29%. Over the last six quarters, Apple has recorded several small beats. These include -9.23% in November 12, 2025.

The stock is currently mid-range between its 52-week high and low $0.23 and $8.52. With a market capitalization of about $1.02 million, Allurion Technologies Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.17). Key stats such as the average daily volume over the past year has been around 4.33 thousand shares, volume is running light vs its 52-week average. Headquartered in Natick, MA, Allurion Technologies Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Shantanu K. Gaur, the company employs approximately 40 people and listed since March 29, 2021. Allurion Technologies Inc. is dedicated to combating obesity by offering a comprehensive weight management ecosystem designed for individuals with excess weight.

Allurion Technologies Inc. has 1.00 million shares outstanding. The public float is 968.70 thousand shares, elevated short interest at 8.98% of float. This equals 71.04 thousand shares. The short ratio is 0.16 days. Institutional investors hold 1.24% of the float. Insiders own 5.18%.

Allurion Technologies Inc. trades at a P/E ratio of -0.02, slightly below the S&P 500 average, with a price-to-sales ratio of 0.08 and a price-to-book ratio of -0.01 indicating negative book value, which may reflect financial stress. The P/FCF stands at -0.04, also above market averages.

Allurion Technologies Inc. (NYSE:ALUR) shares are up 30.08% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Allurion Technologies Inc. trading at a premium to the broader market with a P/E of -0.02. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $4.43, suggesting 310.19% upside. Our AI forecast model points to short-term weakness (-100.0% over two weeks), a medium-term fall (-97.22% over three months), and a longer-term loss (-98.15% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Allurion Technologies Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -100.0%, with price expected at $0.00 by October 05, 2026, within a range of $0.00 to $0.14 3-Month Outlook: Projected fall of -97.22%, reaching $0.03 by December 18, 2026, with a range of $0.00 to $2.29. 1-Year Outlook: Projected loss of -98.15%, with price at $0.02 by September 21, 2027, within a range of $0.00 to $28.07.